Clin2
NCT07379190Possibly a fitRecruiting

Tirofiban for late window stroke due to artery plaque

Stroke, AcuteStroke, IschemicCerebral Infarction

Treatments studied

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
458 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • Your stroke happened more than 24 hours ago but within the last 7 days
  • A special MRI shows your stroke is from plaque buildup in a large artery in the front of your brain
  • You have not had any bleeding in the brain
  • Your stroke symptoms are moderate (score 4-20 on a stroke severity test)
  • You do not have atrial fibrillation or a heart valve that needs blood thinners

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06587347Not yet recruiting· Phase 2/Phase 3
Tirofiban to prevent stroke worsening after clot buster

This study tests whether a medication called tirofiban can help prevent stroke symptoms from getting worse after receiving a clot-busting drug. It is for patients with a narrowed brain artery and ongoing moderate to severe symptoms.

Beijing, Beijing Municipality
NCT07135089Recruiting· Phase 3
Tirofiban before clot removal for large artery stroke

This trial tests whether adding a clot-preventing medication called tirofiban before a mechanical clot removal procedure can improve recovery in people with a certain type of stroke. It's for those with a large artery blockage in the front part of the brain who are able to start the procedure within 12 hours.

Shenyang, Liaoning
NCT06548971Recruiting· Phase 3
Early antiplatelet after clot-busting for stroke (TREND-IVT)

This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.

Bengbu, Anhui
NCT07537933Not yet recruiting· Phase 3
Blood Thinner Injection During Stroke Clot Removal

This trial tests whether injecting a blood thinner called tirofiban directly into brain blood vessels during a stroke procedure helps prevent clots from forming again. If you've had a stroke caused by a large clot in your brain that was successfully removed, this study may help protect your recovery.

Jinan, Shandong
NCT06373042Not yet recruiting· Phase 2/Phase 3
Tirofiban after successful stroke clot removal

This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.

NCT07111806Not yet recruiting· Phase 3
Tirofiban after delayed clot-dissolving treatment for stroke

This trial tests if a medication called tirofiban can help people who had a stroke 4.5 to 24 hours ago and received clot-dissolving treatment (IVT). If you have had a stroke and your symptoms did not improve or got worse after IVT, this study might offer a way to prevent further disability.

Guangzhou, Guangdong

Hear when a new Stroke, Acute trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.